Ocrelizumab for multiple sclerosis

Lin, MB; Zhang, J; Zhang, YL; Luo, JF; Shi, SL

Shi, SL (通讯作者)，Guangxi Med Univ, Dept Neurol, Affiliated Hosp 2, Nanning, Peoples R China.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022; (5):

Abstract

Background Ocrelizumab is a humanised anti-CD20 monoclonal antibody developed for the treatment of multiple sclerosis (MS). It was approved by the Foo......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索